DXTRQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DXTRQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2024-04-28), Dex Liquidating Co's Intrinsic Value: Projected FCF is $0.00. The stock price of Dex Liquidating Co is $0.03306. Therefore, Dex Liquidating Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.
The historical rank and industry rank for Dex Liquidating Co's Intrinsic Value: Projected FCF or its related term are showing as below:
The historical data trend for Dex Liquidating Co's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dex Liquidating Co Annual Data | |||||||||||||||||||||
Trend | Jun08 | Jun09 | Jun10 | Jun11 | Jun12 | Jun13 | Jun14 | Jun15 | Jun16 | Jun17 | |||||||||||
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial | -20.73 | -10.19 | -10.53 | -12.58 | -3.68 |
Dex Liquidating Co Quarterly Data | ||||||||||||||||||||
Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | |
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial | -14.94 | -15.35 | -16.15 | -3.68 | -3.30 |
For the Shell Companies subindustry, Dex Liquidating Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Diversified Financial Services industry and Financial Services sector, Dex Liquidating Co's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Dex Liquidating Co's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)
In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)
Add all the Free Cash Flow together and divide 6 will get Dex Liquidating Co's Free Cash Flow(6 year avg) = $-14.50.
Dex Liquidating Co's Intrinsic Value: Projected FCF for today is calculated as
Intrinsic Value: Projected FCF | = | (Growth Multiple | * | Free Cash Flow (6 year avg) | + | Total Stockholders Equity (Sep17) | / | 0.8) | / | Shares Outstanding (Diluted Average) |
= | (9.5203515959648 | * | -14.49536 | + | -8.291 | / | 0.8) | / | 45.199 | |
= | -3.28 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dex Liquidating Co (OTCPK:DXTRQ) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Dex Liquidating Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF | = | Share Price | / | Intrinsic Value: Projected FCF |
= | 0.03306 | / | -3.2824769067918 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Dex Liquidating Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Younger William H Jr | other: Former Director | 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005 |
Newell Robert Y Iv | officer: V.P., Finance, CFO, Secretary | 2309 BERING DRIVE, SAN JOSE CA 95131 |
Liam Burns | officer: VP,Worldwide Sales & Marketing | C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025 |
Gregory D Casciaro | director | 361 RAQUEL LANE, LOS ALTOS CA 94022 |
Samuel E Navarro | director | C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044 |
Richard M Ferrari | 10 percent owner, other: See Explanation of Responses | 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050 |
Broadfin Healthcare Master Fund Ltd | 10 percent owner, other: See Explanation of Responses | C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108 |
Broadfin Capital, Llc | 10 percent owner, other: See Explanation of Responses | 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022 |
Kevin Kotler | 10 percent owner, other: See Explanation of Responses | C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022 |
Gary S Petersmeyer | director | 3400 CENTRAL AVENUE, SANTA CLARA CA 95051 |
James C Gaither | 10 percent owner | 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005 |
Baker G Leonard Jr | 10 percent owner | 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005 |
Tench Coxe | 10 percent owner | 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304 |
Pullara Samuel J Iii | 10 percent owner | 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304 |
Hill Ventures Sutter | 10 percent owner | 755 PAGE MILL RD, SUITE A200, PALO ALTO CA 94304 |
From GuruFocus
By gurufocus 10qk • 05-17-2010
By GuruFocus Research GuruFocus Editor • 11-05-2009
By guruek gurujk • 11-07-2009
By gurufocus 10qk • 11-15-2010
By gurufocus 10qk • 02-11-2011
By GuruFocus Research GuruFocus Editor • 10-03-2009
By GuruFocus Research GuruFocus Editor • 10-03-2009
By guruek gurujk • 10-11-2009
By Jae Jun Jae Jun • 02-17-2016
By gurufocus 10qk • 11-06-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.